Promoter methylation and protein expression of the E-cadherin gene in the clinicopathologic assessment of adenoid cystic carcinoma

• Published in: Modern pathology Vol. 17; no. 6; pp. 637 - 645
• Main Authors: Maruya, Shin-ichiro, Kurotaki, Hidekachi, Wada, Ryuichi, Saku, Takashi, Shinkawa, Hideichi, Yagihashi, Soroku
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2004; Elsevier Limited
• Subjects: 5-azacytidine; adenoid cystic carcinoma; Adult; Aged; Aged, 80 and over; Base Sequence; Cadherins - biosynthesis; Cadherins - genetics; Cancer; Carcinoma, Adenoid Cystic - genetics; Carcinoma, Adenoid Cystic - metabolism; Carcinoma, Adenoid Cystic - pathology; Cell adhesion & migration; Cell cycle; Cell Line, Tumor; CpG Islands - genetics; DNA Methylation; DNA, Neoplasm - chemistry; DNA, Neoplasm - genetics; DNA, Neoplasm - metabolism; E-cadherin; Exocrine glands; Female; Humans; Immunohistochemistry; Male; Metastasis; methylation; Microdissection - methods; Middle Aged; Otolaryngology; Pathology; Promoter Regions, Genetic - genetics; Protein expression; Proteins; salivary gland carcinoma; Sequence Analysis, DNA; Survival Analysis; Tumors; Japan; 5-azacytidine; adenoid cystic carcinoma; salivary gland carcinoma; E-cadherin; methylation
• ISSN: 0893-3952; 1530-0285
• DOI: 10.1038/modpathol.3800104

Adenoid cystic carcinoma, a relatively uncommon tumor of salivary glands, is characterized by a prolonged clinical course and a fatal outcome. The molecular events underlying their progression are unknown. In this study, we examined the methylation status of E-cadherin gene and its protein expression in 23 cases of adenoid cystic carcinoma and correlated the results with the clinicopathologic factors to determine its role in these tumors. We also analyzed the effect of 5-azacytidine on the re-expression in a methylated cell line of adenoid cystic carcinoma for this gene. In our study, E-cadherin immunoreactivity, although heterogeneous, showed a progressive reduction with high histological grade and in metastatic and recurrent lesions. Promoter methylation was detected in 16 of 23 cases (70%), but there was no correlation with the histological grade or patient prognosis. Microdissection of immuno-negative cells in heterogeneous tumors showed positive methlyation. In the cell line from salivary adenoid cystic carcinoma with methylated E-cadherin, 5-azacytidine restored the E-cadherin expression. Our results indicate that: (1) E-cadherin gene promoter is frequently methylated in adenoid cystic carcinoma, leading to reduced E-cadherin expression, (2) variable E-cadherin expression might result from the intratumoral heterogeneity, and (3) increased extent of methylated areas may be associated with progression and advancement of the disease.